This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Sanofi. Active years: 2013-2014.
Location History:
- Darmstadt, DE (2013 - 2014)
- Frankfurt-am-Main, DE (2014)
Company Filing History:
Years Active: 2013-2014
Title: **Peter Monecke: Innovator in Isoquinoline Derivatives**
Introduction
Peter Monecke, an accomplished inventor based in Darmstadt, Germany, has made significant contributions in the field of medicinal chemistry. With a total of three patents to his name, Monecke is recognized for his innovative work on isoquinoline derivatives, which have promising applications in the treatment of various diseases.
Latest Patents
Monecke's recent patents focus on the development of 6-piperidinyl-substituted isoquinoline derivatives and cycloalkylamine substituted isoquinoline derivatives. These inventions relate to compounds that are beneficial for the treatment and/or prevention of diseases associated with Rho-kinase and the Rho-kinase mediated phosphorylation of myosin light chain phosphatase. His work emphasizes the importance of these compounds and their compositions in advancing therapeutic options for patients.
Career Highlights
Throughout his career, Peter Monecke has been associated with Sanofi, a leading global healthcare company where he has honed his expertise in pharmaceutical innovation. His dedication to research and development has positioned him as a key player in his field.
Collaborations
Monecke collaborates with fellow inventors and researchers, including Oliver Plettenburg and Armin Hofmeister, to further enhance the scope of his innovations. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in developing groundbreaking technologies.
Conclusion
In conclusion, Peter Monecke's contributions to the field of isoquinoline derivatives underscore the impact of dedicated inventors in advancing medical science. His innovative patents not only reflect his expertise but also serve as a foundation for future research and development within the pharmaceutical industry.